WuXi AppTec (OTCMKTS:WUXAY – Get Free Report) will likely be releasing its results after the market closes on Monday, October 26th. Analysts expect WuXi AppTec to post earnings of $0.4377 per share and revenue of $2.39 billion for the quarter.
WuXi AppTec Stock Down 0.8%
OTCMKTS WUXAY opened at $23.71 on Friday. The company has a 50-day simple moving average of $25.72 and a 200-day simple moving average of $20.84. WuXi AppTec has a one year low of $12.45 and a one year high of $28.69.
Wall Street Analysts Forecast Growth
Separately, Zacks Research cut shares of WuXi AppTec from a “strong-buy” rating to a “hold” rating in a report on Monday, October 5th. One investment analyst has rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, WuXi AppTec has a consensus rating of “Moderate Buy”.
WuXi AppTec Company Profile
WuXi AppTec is a global pharmaceutical and biotechnology services company that provides contract research, development and manufacturing services. The company supports drug developers throughout the product life cycle, from early-stage discovery and laboratory testing through clinical development and commercial production.
Its offerings include medicinal and synthetic chemistry, biology research, preclinical and clinical testing, regulatory support, pharmaceutical manufacturing, and the development and manufacturing of advanced therapies.
Featured Stories
- Five stocks we like better than WuXi AppTec
- Bloom Energy Just Reported—Its Biggest Order Is Still Waiting on a Pipeline
- Why Western Digital’s AI Storage Boom Defies the Chip Sell-Off
- Grand Canyon Education Strengthens Its Outlook, But Wall Street Remains Divided
- Amex Stock Slides on Job Cuts, But the Real Story Is Macro
Receive News & Ratings for WuXi AppTec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi AppTec and related companies with MarketBeat.com's FREE daily email newsletter.
